RSClin® Tool N+ Enhances Accuracy in Recurrence Risk Estimation and Chemotherapy Benefit for Node-Positive Breast Cancer
A groundbreaking statistical tool has emerged that enhances the ability to predict breast cancer prognosis and treatment response for patients ...
